WO2025141422 - -CARBAMOYL ASPARTIC ACID COMPOUNDS IN THE PREPARATION OF MEDICAMENTS FOR TREATING COCCIDIOSIS IN ANIMALS
National phase entry is expected:
Publication Number
WO/2025/141422
Publication Date
03.07.2025
International Application No.
PCT/IB2024/062950
International Filing Date
20.12.2024
Title **
[English]
-CARBAMOYL ASPARTIC ACID COMPOUNDS IN THE PREPARATION OF MEDICAMENTS FOR TREATING COCCIDIOSIS IN ANIMALS
[French]
-CARBAMOYL-ASPARTIQUE DANS LA PRÉPARATION DE MÉDICAMENTS POUR LE TRAITEMENT DE LA COCCIDIOSE CHEZ L'ANIMAL
Applicants **
ANIPHA TECHNOLOGIES PTY LTD
Inventors
PENG, Xianfeng
Priority Data
202311827973.8
28.12.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2099 | |
| EPO | Filing, Examination, Granting | 11587 | |
| Japan | Filing, Examination, Granting | 2178 | |
| South Korea | Filing, Examination, Granting | 2107 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,711
Contact Us
Abstract[English]
alkyl. The N-carbamoyl aspartic acid compound or a racemate, stereoisomer, geometric isomer, tautomer, solvate, or pharmaceutically acceptable salt thereof as described herein, or a pharmaceutical composition comprising the same is remarkably effective against coccidiosis, and showed an obvious dose response.[French]
linéaire ou ramifié. Le composé d'acide N-carbamoyl-aspartique ou un racémate, un stéréoisomère, un isomère géométrique, un tautomère, un solvate ou un sel pharmaceutiquement acceptable de celui-ci tel que décrit ici, ou une composition pharmaceutique le comprenant est remarquablement efficace contre la coccidiose, et a montré une relation dose-réponse évidente.